Dig­i­tal­is makes its de­but with $100M fund and a yen for ‘deeply tech­ni­cal peo­ple’

A new fund has land­ed in the life sci­ences/health­care field. Wel­come Dig­i­tal­is, which is look­ing for a new breed of com­pa­ny to back with its $100 mil­lion in in­vest­ment cash.

“I want­ed to build a firm with an ori­en­ta­tion to health rather than dis­ease,” says Ge­of­frey W. Smith, the founder and man­ag­ing part­ner of Dig­i­tal­is.

Smith isn’t in­ter­est­ed in your av­er­age biotech play, hunt­ing up an as­set with re­al po­ten­tial and point­ing it to the clin­ic. He al­so wasn’t look­ing for any spe­cif­ic in­for­ma­tion tech project. Rather, he wants to find am­bi­tious thinkers ad­vanc­ing en­gi­neered so­lu­tions to big prob­lems, the way CRISPR, for ex­am­ple, has promised to rev­o­lu­tion­ize drug de­vel­op­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER